CRISPR Therapeutics AG (CRSP)
NASDAQ: CRSP · Real-Time Price · USD
47.96
+0.97 (2.06%)
Jul 21, 2026, 12:13 PM EDT - Market open
CRISPR Therapeutics AG Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $80 | Buy | Reiterates | $80 | +66.81% | Jul 8, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains $83 | Buy | Maintains | $83 | +73.06% | Jul 7, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $110 | Buy | Reiterates | $110 | +129.36% | Jul 2, 2026 |
| Needham | Needham | Buy Maintains $82 | Buy | Maintains | $82 | +70.98% | Jun 24, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Upgrades $60 | Hold | Upgrades | $60 | +25.10% | Jun 11, 2026 |
Unknown Analyst Mizuho Securities No rating | Mizuho Securities | Buy Maintains $85 | Buy | Maintains | $85 | +77.23% | Jun 10, 2026 |
| William Blair | William Blair | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Jun 4, 2026 |
| Bernstein | Bernstein | Hold Reiterates $50 → $56 | Hold | Reiterates | $50 → $56 | +16.76% | May 13, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.